Zymeworks (NASDAQ:ZYME) executives used the company’s fourth-quarter 2025 results call to highlight updated clinical data for ...

Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) to be completed by our partner Jazz in first-line HER2-positive ...

Zymeworks to receive $250 million under a royalty-backed note financing from Royalty Pharma with repayments due from 30% of worldwide tiered royalties on Ziihera until fully repaidZymeworks to retain ...

Jill Blumberg of Practical Law asked leading real estate practitioners to share their thoughts on recent developments impacting the US commercial real estate market.

An explanation of insider status in bankruptcy and restructuring cases, including the risks and implications of insider ...

This case study can provide practical instruction to students and entry-level accounting staff in key issues of state ...

Case Equity Partners (CASE), a commercial real estate investment and advisory firm specializing in distressed and structured-finance situations, today announced the release of a new white paper, ...

Versant Funding funded a $5 million non-recourse factoring facility to a company that manufactures products for a large customer base which includes one of America’s largest municipalities. After a ...

With recourse factoring, you're responsible for the debt if your customers don’t pay. With non-recourse factoring, the factoring company accepts the loss for nonpayment. Many, or all, of the products ...